Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Craig Miller

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 23, 2025
The utility of the novel biomarker HE4 for monitoring epithelial ovarian cancer during PARP inhibitor treatmentAlexandra Morell, Anne Stoklosa, Alexandra Blackman, et al.
Clinical Chemistry|September 27, 2002
Comparison of logistic regression and neural net modeling for prediction of prostate cancer pathologic stageRobert W Veltri, Manisha Chaudhari, M Craig Miller, et al.
The Journal of Urology|June 7, 2002
Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challengeRobert W Veltri, M Craig Miller, Leslie A Mangold, et al.
The Prostate|September 4, 2008
Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesisRobert W Veltri, Sumit Isharwal, M Craig Miller, et al.
Urology|April 19, 2005
Circulating tumor cells predict survival in patients with metastatic prostate cancerJose G Moreno, M Craig Miller, Steve Gross, et al.
Urology|February 6, 2009
DNA Ploidy as surrogate for biopsy gleason score for preoperative organ versus nonorgan-confined prostate cancer predictionSumit Isharwal, M Craig Miller, Jonathan I Epstein, et al.
Obstetrics and Gynecology|July 22, 2011
Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic massRichard G Moore, M Craig Miller, Paul Disilvestro, et al.
Gynecologic Oncology|April 18, 2019
Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?Richard G Moore, Alexandra Blackman, M Craig Miller, et al.
The Prostate|March 10, 2018
PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysisNeil M Carleton, Guangjing Zhu, Mikhail Gorbounov, et al.
International Journal of Oncology|June 9, 2005
Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumorsChandra G Rao, David Chianese, Gerald V Doyle, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 23, 2025
The utility of the novel biomarker HE4 for monitoring epithelial ovarian cancer during PARP inhibitor treatmentAlexandra Morell, Anne Stoklosa, Alexandra Blackman, et al.
Clinical Chemistry|September 27, 2002
Comparison of logistic regression and neural net modeling for prediction of prostate cancer pathologic stageRobert W Veltri, Manisha Chaudhari, M Craig Miller, et al.
The Journal of Urology|June 7, 2002
Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challengeRobert W Veltri, M Craig Miller, Leslie A Mangold, et al.
The Prostate|September 4, 2008
Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesisRobert W Veltri, Sumit Isharwal, M Craig Miller, et al.
Urology|April 19, 2005
Circulating tumor cells predict survival in patients with metastatic prostate cancerJose G Moreno, M Craig Miller, Steve Gross, et al.
Urology|February 6, 2009
DNA Ploidy as surrogate for biopsy gleason score for preoperative organ versus nonorgan-confined prostate cancer predictionSumit Isharwal, M Craig Miller, Jonathan I Epstein, et al.
Obstetrics and Gynecology|July 22, 2011
Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic massRichard G Moore, M Craig Miller, Paul Disilvestro, et al.
Gynecologic Oncology|April 18, 2019
Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?Richard G Moore, Alexandra Blackman, M Craig Miller, et al.
The Prostate|March 10, 2018
PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysisNeil M Carleton, Guangjing Zhu, Mikhail Gorbounov, et al.
International Journal of Oncology|June 9, 2005
Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumorsChandra G Rao, David Chianese, Gerald V Doyle, et al.
Pageof 6